Paras Healthcare Completes Rs 1,450 Crore Initial Public Offering with Debut on BSE and NSE
Multi-specialty hospital chain operator Paras Healthcare Limited has completed its initial public offering (IPO) of Rs 1,450 crore (approximately $153 million), formally concluding its journey to the public markets with a debut on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Gurugram-headquartered healthcare provider priced its equity shares at the upper band of Rs 693 per share after bidding ran from October 21 to October 23, 2026. The stock debuted on the bourses at Rs 720, registering a listing premium of nearly 4% before moving higher in subsequent trading sessions.
Issue Breakdown and Anchor Participation
The public offer was structured as a combination of fresh capital issuance and secondary share sales:
- Fresh Issue: ₹500 crore through the issuance of 72.15 lakh new equity shares.
- Offer for Sale (OFS): ₹950 crore through 1.37 crore equity shares sold by promoter Dr. Dharminder Kumar Nagar and private equity investor Commelina Ltd, an affiliate of Creador.
Ahead of opening to the public, the company mobilised Rs 652.50 crore from anchor investors on October 19. The anchor book witnessed robust foreign and domestic participation from premier global sovereign wealth and asset management funds, including the Abu Dhabi Investment Authority (ADIA) and BlackRock. The overall book closed subscribed 2.23 times across categories.
The underwriting and book-building process was steered by book-running lead managers JM Financial, BofA Securities India, and Nuvama Wealth Management. Legal advisory roles were handled by AZB & Partners, S&R Associates, and Hogan Lovells Cadwalader.
Balance Sheet Deleveraging and Utilization of Proceeds
A central highlight of the offering for retail and institutional investors is the company’s capital allocation roadmap. Paras Healthcare has earmarked approximately Rs 375 crore from the fresh issue proceeds toward scheduled debt reduction. This includes repaying outstanding borrowings of Paras Healthcare Limited as well as debt held by its wholly owned subsidiary, Plus Medicare Hospitals Private Limited, which operates its facility in Srinagar.
The remainder of the fresh funds will support general corporate objectives. Deleveraging is expected to significantly reduce interest liabilities, strengthening bottom-line performance as several of its newer facilities enter high-margin operational phases.
Operational Footprint and Expansion Pipeline
Founded in Gurugram in 2006, Paras Healthcare provides tertiary and quaternary medical care under the "Paras Health" brand. As of June 30, 2026, the company operated eight hospitals with a cumulative capacity of 2,211 beds. Its geographic presence covers five Indian states and one Union Territory, with hospitals situated in Gurugram and Panchkula (Haryana), Patna and Darbhanga (Bihar), Kanpur (Uttar Pradesh), Udaipur (Rajasthan), Ranchi (Jharkhand), and Srinagar (Jammu & Kashmir).
The healthcare operator focuses heavily on high-acuity therapeutic verticals, such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal care—specialties that generated nearly 75% of operations revenue in FY26. Revenue from operations increased from Rs 1,129.04 crore in FY24 to Rs 1,605.95 crore in FY26, alongside an expansion in EBITDA to Rs 335.58 crore.
Paras Healthcare has outlined plans to scale its bed capacity to 3,011 beds by March 31, 2028, backed by planned hospital additions in Gurugram (300 beds) and Ludhiana (500 beds). For Indian market observers, the transaction reflects the investment community's appetite for hospital networks capitalizing on underserved healthcare corridors outside tier-1 metropolitan clusters.
